Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

B Coiffier; B Pro; HM Prince; FM Foss; L Sokol; M Greenwood; D Caballero; P Borchmann; F Morschhauser; Martin Wilhelm; L Pinter-Brown; S Padmanabhan; A Shustov; J Nichols; S Carroll; J Balser; SM Horwitz

Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

B Coiffier, B Pro, HM Prince, FM Foss, L Sokol, M Greenwood, D Caballero, P Borchmann, F Morschhauser, Martin Wilhelm, L Pinter-Brown, S Padmanabhan, A Shustov, J Nichols, S Carroll, J Balser, SM Horwitz

Department of Internal Medicine V, Division of Oncology and Hematology

Research output: Contribution to journal › Abstract (Journal) › peer-review

Original language	English
Pages (from-to)	56-57
Journal	BLOOD
Volume	116
Issue number	21
Publication status	Published - 2010
Event	52nd Annual Meeting of the American-Society-of-Hematology (ASH) - Orlando, FL Duration: 4 Dec 2010 → 7 Dec 2010

Cite this

Coiffier, B., Pro, B., Prince, HM., Foss, FM., Sokol, L., Greenwood, M., Caballero, D., Borchmann, P., Morschhauser, F., Wilhelm, M., Pinter-Brown, L., Padmanabhan, S., Shustov, A., Nichols, J., Carroll, S., Balser, J., & Horwitz, SM. (2010). Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy. BLOOD , 116(21), 56-57.

Coiffier, B ; Pro, B ; Prince, HM et al. / Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy. In: BLOOD 2010 ; Vol. 116, No. 21. pp. 56-57.

@article{08bc727181f746ab9617eb0bc2c36aca,

title = "Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy",

author = "B Coiffier and B Pro and HM Prince and FM Foss and L Sokol and M Greenwood and D Caballero and P Borchmann and F Morschhauser and Martin Wilhelm and L Pinter-Brown and S Padmanabhan and A Shustov and J Nichols and S Carroll and J Balser and SM Horwitz",

year = "2010",

language = "English",

volume = "116",

pages = "56--57",

journal = "BLOOD ",

issn = "0006-4971",

publisher = "American Society of Hematology ",

number = "21",

note = "52nd Annual Meeting of the American-Society-of-Hematology (ASH) ; Conference date: 04-12-2010 Through 07-12-2010",

}

Coiffier, B, Pro, B, Prince, HM, Foss, FM, Sokol, L, Greenwood, M, Caballero, D, Borchmann, P, Morschhauser, F, Wilhelm, M, Pinter-Brown, L, Padmanabhan, S, Shustov, A, Nichols, J, Carroll, S, Balser, J & Horwitz, SM 2010, 'Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy', BLOOD , vol. 116, no. 21, pp. 56-57.

Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy. / Coiffier, B; Pro, B; Prince, HM et al.
In: BLOOD , Vol. 116, No. 21, 2010, p. 56-57.

Research output: Contribution to journal › Abstract (Journal) › peer-review

TY - JOUR

T1 - Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy

AU - Coiffier, B

AU - Pro, B

AU - Prince, HM

AU - Foss, FM

AU - Sokol, L

AU - Greenwood, M

AU - Caballero, D

AU - Borchmann, P

AU - Morschhauser, F

AU - Wilhelm, Martin

AU - Pinter-Brown, L

AU - Padmanabhan, S

AU - Shustov, A

AU - Nichols, J

AU - Carroll, S

AU - Balser, J

AU - Horwitz, SM

PY - 2010

Y1 - 2010

M3 - Abstract (Journal)

SN - 0006-4971

VL - 116

SP - 56

EP - 57

JO - BLOOD

JF - BLOOD

IS - 21

T2 - 52nd Annual Meeting of the American-Society-of-Hematology (ASH)

Y2 - 4 December 2010 through 7 December 2010

ER -

Coiffier B, Pro B, Prince HM, Foss FM, Sokol L, Greenwood M et al. Final Results From a Pivotal, Multicenter, International, Open Label, Phase 2 Study of Romidepsin In Progressive or Relapsed Peripheral T-Cell Lymphoma (PTCL) Following Prior Systemic Therapy. BLOOD . 2010;116(21):56-57.